Synlett 2016; 27(06): 965-968
DOI: 10.1055/s-0035-1561500
letter
© Georg Thieme Verlag Stuttgart · New York

A Novel Synthesis of Disubstituted Quinazoline Diones with Differential N-Substitution via a Copper-Catalysed Cross-Coupling of Acyl Ureas

Emma Durham
,
Dave Perkins*
,
James S. Scott
,
Jimmy Wang
,
Sam Watson
Further Information

Publication History

Received: 19 October 2015

Accepted after revision: 21 November 2015

Publication Date:
28 December 2015 (online)


Abstract

An efficient method for the synthesis of disubstituted quinazoline diones with differential N-substitution is reported. A wide range of substitutions on the aromatic and dione rings are tolerated, and the reaction proceeds in high yields under mild conditions.

Supporting Information

 
  • References and Notes

  • 1 New address: Emma Durham, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
  • 2 New address: Jimmy Wang, Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
  • 3 New address: Sam Watson, School of Chemistry, University of St. Andrews, St. Andrews, KY16 9ST, UK.
  • 4 Eckhardt M, Langkoft E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Seiger P, Fuchs H, Himmelsbach F. J. Med. Chem. 2007; 50: 6450
  • 5 Noda K, Nakagawa A, Hachiya T, Ide H. US 4016166 A1, 1977
  • 6 Schneller SW, Ibay AC, Christ WJ, Bruns RF. J. Med. Chem. 1989; 32: 2247
  • 7 Hedayatullah M. J. Heterocycl. Chem. 1981; 18: 339
  • 8 Reisch J, Rao AR. R, Usifoh CO. Monatsh. Chem. 1993; 124: 1217
  • 9 Li P, Zhan C, Zhang S, Yao J, Guo F, Ding X, He S. Tetrahedron 2012; 68: 8908
  • 10 Usifoh CO, Scriba GK. E. Arch Pharm. 2000; 333: 261
  • 11 Unpublished results involved the reaction of quinazoline dione with n-butanol under Mitsunobu conditions (DIAD, Ph3P, DMF, r.t.). Selective alkylation of N3 was observed (isolated yield 23%) with no evidence of the N1-monoalkylated product being formed. However, attempts to increase the yield and optimise conditions led to increased amounts of the N1,N3-disubstituted product in our hands.
  • 12 Clark RL, Clements CJ, Barrett MP, MacKay SP, Rathnam RP, Owusu-Dapaah G, Spencer J, Huggan JK. Bioorg. Med. Chem. 2012; 20: 6019
  • 13 Matharu DS, Flaherty DP, Simpson DS, Schroeder CE, Chung D, Yan D, Noah JW, Jonsson CB, White LE, Aub J, Plemper RK, Severson WE, Golden JE. J. Med. Chem. 2014; 57: 10314
  • 14 Stokes S, Martin NG. Tetrahedron Lett. 2012; 53: 4802
  • 15 Li Z, Sun H, Liu H. Org. Lett. 2008; 10: 3263
  • 16 General Procedure (Table 2, Entry 1) Copper(I) iodide (0.019 g, 0.10 mmol) was added to N-(ethylcarbamoyl)-2-iodo-N-methylbenzamide (0.33 g, 0.99 mmol), (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (0.026 g, 0.20 mmol), and K2CO3 (0.412 g, 2.98 mmol) in DMF (18 mL) at 20 °C under nitrogen. The resulting suspension was stirred at 50 °C for 5 h. The reaction mixture was filtered to remove the K2CO3 and evaporated under reduced pressure to remove the DMF. The residue was purified by flash silica chromatography, elution gradient 0–100% EtOAc in heptane. Pure fractions were evaporated to dryness to afford 1-ethyl-3-methylquinazoline-2,4(1H,3H)-dione (0.160 g, 79%) as a white crystalline solid. 1H NMR (400 MHz, CDCl3): δ = 1.36 (t, J = 7.1 Hz, 3 H), 3.49 (s, 3 H), 4.21 (q, J = 7.1 Hz, 2 H), 7.19–7.25 (m, 2 H), 7.67 (ddd, J = 1.7, 7.3, 8.5 Hz, 1 H), 8.25 (ddd, J = 0.4, 1.6, 7.9 Hz, 1 H). 13C NMR (101 MHz, CDCl3): δ = 12.59, 28.35, 38.81, 113.33, 115.74, 122.71, 129.17, 134.97, 139.51, 150.79, 162.00. MS (ES+): m/z = 205.0973 [M + H]+. For complete data, see Supporting Information.